PT Siloam International Hospitals (SILO) Q3 2024 earnings summary

Executive summary

• Revenue for the nine months ended September 30, 2024, reached Rp9,123,173 million, up from Rp8,245,600 million year-over-year.

• Net profit for the period was Rp669,317 million, a decrease from Rp883,832 million in the same period last year.

• Gross profit increased to Rp3,613,025 million from Rp3,230,670 million year-over-year.

• Total assets as of September 30, 2024, were Rp11,723,495 million, up from Rp10,982,062 million at December 31, 2023.

• The company paid a cash dividend of Rp259,645 million for 2023 on June 27, 2024.

Financial highlights

• Revenue grew 10.6% year-over-year for the nine months ended September 30, 2024.

• Net profit margin declined to 7.3% from 10.7% year-over-year.

• Earnings per share (basic) were Rp48.90, down from Rp66.23 year-over-year.

• Total equity increased to Rp8,444,214 million from Rp8,047,636 million at year-end 2023.

• Cash and cash equivalents stood at Rp961,526 million as of September 30, 2024.

Outlook and guidance

• Management continues to focus on operational efficiency and expansion of hospital services across Indonesia.

• Ongoing capital projects are expected to be completed between 2025 and 2027.